Dr. David H. Ilson is a leading medical oncologist at MSKCC, where he dedicates his practice to treating patients with gastric and esophageal cancers. He earned his medical degree from New York University School of Medicine and completed his residency in Internal Medicine at the University of California, San Francisco. Dr. Ilson is board-certified in Medical Oncology and Internal Medicine. He is a respected researcher and educator, serving as a professor at Weill Cornell Medical College and mentoring the next generation of oncologists.
Dr. David H. Ilson has over 30 years of clinical experience specializing in gastrointestinal oncology, with a particular focus on stomach and esophageal cancers. He is renowned for his expertise in developing and implementing novel chemotherapy regimens and has been instrumental in advancing the standard of care for gastric cancer patients. Dr. Ilson is actively involved in clinical trials, offering patients access to cutting-edge therapies and personalized treatment plans.
Dr. David H. Ilson is a leading medical oncologist at MSKCC, where he dedicates his practice to treating patients with gastric and esophageal cancers. He earned his medical degree from New York University School of Medicine and completed his residency in Internal Medicine at the University of California, San Francisco. Dr. Ilson is board-certified in Medical Oncology and Internal Medicine. He is a respected researcher and educator, serving as a professor at Weill Cornell Medical College and mentoring the next generation of oncologists.